{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:48:16Z","timestamp":1786794496136,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.msard.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T23:09:57Z","timestamp":1465686597000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis"],"prefix":"10.1016","volume":"9","author":[{"given":"Lijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2016.05.008_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2008.04.053","article-title":"The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice","volume":"439","author":"Allameh","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.msard.2016.05.008_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jocn.2012.05.054","article-title":"Serum uric acid level in patients with relapsing-remitting multiple sclerosis","volume":"20","author":"Ashtari","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.msard.2016.05.008_bib3","doi-asserted-by":"crossref","unstructured":"B Tavazzi, AP Batocchi, AM Amorini, et al. Serum metabolic profile in multiple sclerosis patients. Mult Scler Int. 2011;2011:167156.","DOI":"10.1155\/2011\/167156"},{"key":"10.1016\/j.msard.2016.05.008_bib4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1515\/CCLM.2009.192","article-title":"Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis","volume":"47","author":"Dujmovic","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.msard.2016.05.008_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10072-011-0488-5","article-title":"Serum uric acid levels in multiple sclerosis patients inversely correlate with disability","volume":"32","author":"Guerrero","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2016.05.008_bib6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1073\/pnas.95.2.675","article-title":"Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis","volume":"95","author":"Hooper","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.msard.2016.05.008_bib7","first-page":"35","article-title":"Uric acid and renal function in multiple sclerosis","volume":"159","author":"Kanabrocki","year":"2008","journal-title":"Clin. Ter."},{"key":"10.1016\/j.msard.2016.05.008_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00415-005-0697-z","article-title":"No evidence of increased oxidative degradation of urate to allantoin in the csf and serum of patients with multiple sclerosis","volume":"252","author":"Kastenbauer","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib9","first-page":"S166","article-title":"Cognitive impairment in early phase of multiple sclerosis and the correlation with plasma uric acid level and mri lesion","volume":"15","author":"Keklikoglu","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2016.05.008_bib10","article-title":"Uric acid levels in patients with multiple sclerosis: A double matched study","volume":"13","author":"Koutoula","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2016.05.008_bib11","first-page":"14","article-title":"Plasma uric acid levels in patients with multiple sclerosis","volume":"222","author":"Kuracka","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2016.05.008_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/1743132811Y.0000000074","article-title":"Serum uric acid levels in patients with multiple sclerosis: A meta-analysis","volume":"34","author":"Liu","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.msard.2016.05.008_bib13","first-page":"88","article-title":"Correlations between serum uric acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis","volume":"27","author":"Liu","year":"2012","journal-title":"Chin. Med. Sci. J."},{"key":"10.1016\/j.msard.2016.05.008_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11011-013-9409-z","article-title":"Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks","volume":"28","author":"Ljubisavljevic","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.msard.2016.05.008_bib15","doi-asserted-by":"crossref","unstructured":"M. Moccia, R. Lanzillo, R. Palladino, et al. Uric acid: A potential biomarker of multiple sclerosis and of its disability. Clin Chem Lab Med. 2014.","DOI":"10.1515\/cclm-2014-0744"},{"key":"10.1016\/j.msard.2016.05.008_bib16","article-title":"Serum uric acid level in iranian patients with multiple sclerosis","volume":"17","author":"Mamarabadi","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/acm.2008.0513","article-title":"The treatment of multiple sclerosis with inosine","volume":"15","author":"Markowitz","year":"2009","journal-title":"J. Altern. Complement Med."},{"key":"10.1016\/j.msard.2016.05.008_bib18","first-page":"337","article-title":"Association between serum uric acid and recovery after multiple sclerosis relapse","volume":"19","author":"Masera","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2016.05.008_bib19","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00415-009-5170-y","article-title":"Serum uric acid and risk of multiple sclerosis","volume":"256","author":"Massa","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2011.09.021","article-title":"Oxidative modification of patient\u2019s plasma proteins and its role in pathogenesis of multiple sclerosis","volume":"45","author":"Miller","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.msard.2016.05.008_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0404.2012.01643.x","article-title":"Reduced serum uric acid levels in neuromyelitis optica: Serum uric acid levels are reduced during relapses in nmo","volume":"126","author":"Min","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2016.05.008_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2004.12.008","article-title":"Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses","volume":"231","author":"Mostert","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2016.05.008_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1352458507082143","article-title":"Serum uric acid levels of patients with multiple sclerosis and other neurological diseases","volume":"14","author":"Peng","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2016.05.008_bib25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00415-010-5455-1","article-title":"Serum uric acid levels and neuromyelitis optica","volume":"257","author":"Peng","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1468-1331.2011.03488.x","article-title":"Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica","volume":"19","author":"Peng","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: Guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib28","article-title":"Serum uric acid concentration in multiple sclerosis","volume":"15","author":"Przybek","year":"2010","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.msard.2016.05.008_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1468-1331.2005.01009.x","article-title":"Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein e genotype in benign vs. Progressive multiple sclerosis","volume":"12","author":"Ramsaransing","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clineuro.2005.08.004","article-title":"Serum uric acid and multiple sclerosis","volume":"108","author":"Rentzos","year":"2006","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2016.05.008_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-511X-9-19","article-title":"Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients","volume":"9","author":"Salemi","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.msard.2016.05.008_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s100720200059","article-title":"Serum uric acid and multiple sclerosis","volume":"23","author":"Sotgiu","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2016.05.008_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.msard.2016.05.008_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-1331.2002.00384.x","article-title":"Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction","volume":"9","author":"Toncev","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2016.05.008_bib35","article-title":"Serum uric acid levels are decreased in patients with relapsing-remitting multiple sclerosis, in particular during relapses","volume":"14","author":"Tsakiri","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2016.05.008_bib36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2016.05.008_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-510X(09)70350-8","article-title":"Serum uric acid levels in chinese classic multiple sclerosis: Pre vs post treatment with ifn-beta 1b","volume":"285","author":"Xu","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2016.05.008_bib38","first-page":"333","article-title":"Relation of serum uric acid level with cognitive functions and number of plaques in patients with relapsing-remitting multiple sclerosis","volume":"47","author":"Yoldas","year":"2010","journal-title":"Noropsikiyatri Arsivi-Archives Neuropsychiatry"},{"key":"10.1016\/j.msard.2016.05.008_bib39","first-page":"935","article-title":"[serum uric acid level and related clinical features in neuromyelitis optica]","volume":"49","author":"You","year":"2010","journal-title":"Zhonghua Nei KE ZA Zhi."},{"key":"10.1016\/j.msard.2016.05.008_bib40","doi-asserted-by":"crossref","first-page":"e40608","DOI":"10.1371\/journal.pone.0040608","article-title":"Low serum urate levels are associated to female gender in multiple sclerosis patients","volume":"7","author":"Zoccolella","year":"2012","journal-title":"PLoS One."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034816300608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034816300608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:39:54Z","timestamp":1761899994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034816300608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":40,"alternative-id":["S2211034816300608"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2016.05.008","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}